TRIAL MANAGEMENT
Investigator SmartSelect
This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
Disclosure As A Service ROI
How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.
Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor
Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.
Practical Approaches To Faster Study Start-Ups
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
The Golden Era Of GLP-1 Drugs
As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
The Difference Between Clinical Trial Auditing And Monitoring
While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.
Exploring The Principles Integral To Rare Disease Drug Development
This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.
CTIS Master Series 1: Are You Ready For CTIS?
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
Think U.S.A.: The Operations Behind Your Clinical Trials
Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
Patient First Solutions For Oncology
Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.
Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency
Karri Venn, VP site advocacy and mentorship at SCRS, emphasized the importance of sponsors recognizing the structure and capabilities of larger site networks.
Altasciences Has You Covered From Coast To Coast
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
Driving Simulation Studies At Altasciences
At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.
Mastering Scope 3 Emissions In Clinical Trials
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
Optimize Protocols For More Successful Trials
Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.
TMF Management In Clinical Trials
Elevate your knowledge of clinical trials and the Trial Master File by exploring three critical topics.
Tackling The EU CTR Compliance Challenge
Maintaining disclosure compliance is tricky enough with ClinicalTrials.gov, but when it comes to EU CTR compliance, the complexity rises to a whole new level. As a sponsor, do you find your organization “guilty” of these common errors?
Accelerate Your Data With Our Co-Located Clinic And Lab
Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.
Cohort Configuration Feature Of An RTSM Platform
Master trial agility by building and prioritizing cohorts in real time. Effortlessly manage dose levels and enrollment limits to keep your study on track, even as protocols evolve.
Clinical Trials And TMF 101 Learning Series: 1st Session
Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.
Keeping Up With ClinOps: Why And How To Improve Delivery
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
Sponsors' Advice On Disclosure As A Service
Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.
Clinical Trials And TMF 101 Learning Series: 2nd Session
The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
What Is The Secret To Ongoing TMF Health?
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
Korio RTSM Platform: Real-Time Audit Trail Demo
Watch a real-time walkthrough of Korio’s built-in audit trail. Human-readable, blind-controlled, and fully exportable—see how sponsors get instant access to critical trial data.
Going From Good To Great As A TMF Champion
Gain insight into regulatory nuances, best practices for documentation management, and strategies for fostering a culture of compliance within the team.
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
